I. V. Maiborodin, I. O. Marinkin, N. V. Onoprienko, V. I. Maiborodina
{"title":"Gonadotropin-Releasing Hormone and Organs of the Immune System","authors":"I. V. Maiborodin, I. O. Marinkin, N. V. Onoprienko, V. I. Maiborodina","doi":"10.1134/s0022093024040197","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Abstract</h3><p>In this review, we address the physiological aspects of the\ngonadotropin-releasing hormone (GnRH) effects on the immune organs,\nsuch as red bone marrow, thymus, spleen, and lymph nodes. The use\nof GnRH drugs leads to the replacement of red bone marrow with yellow\none and an increase in the content of lymphoid and myeloid progenitor\ncells. These processes are paralleled by osteoporosis due to increased\nbone resorption with changes in calcium metabolism and a decrease\nin the density of various bone tissues, although there are opposing\nreports that GnRH has no effect on bone density and calcium metabolism.\nGnRH affects the thymus during both embryonic development and postnatal\nontogenesis, in inflammation and age-related involution. Not only\ndoes GnRH cause changes in the thymus, but the thymus may in turn\ninfluence the GnRH system. Although a direct impact of GnRH on splenic\ncells has not been detected, splenic mass changed due to active\nimmunization against GnRH in experiment. Unfortunately, very few\narticles demonstrate the physiological mechanisms of immunomodulation\nin such conditions. In any case, the obvious insufficiency and inconsistency\nof publications on each aspect of GnRH effects indicate that they\nare still poorly understood, and it is worth furthering not only\napplied but also fundamental studies in this direction, particularly\nin the context of developing effective systems for immune control.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1134/s0022093024040197","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In this review, we address the physiological aspects of the
gonadotropin-releasing hormone (GnRH) effects on the immune organs,
such as red bone marrow, thymus, spleen, and lymph nodes. The use
of GnRH drugs leads to the replacement of red bone marrow with yellow
one and an increase in the content of lymphoid and myeloid progenitor
cells. These processes are paralleled by osteoporosis due to increased
bone resorption with changes in calcium metabolism and a decrease
in the density of various bone tissues, although there are opposing
reports that GnRH has no effect on bone density and calcium metabolism.
GnRH affects the thymus during both embryonic development and postnatal
ontogenesis, in inflammation and age-related involution. Not only
does GnRH cause changes in the thymus, but the thymus may in turn
influence the GnRH system. Although a direct impact of GnRH on splenic
cells has not been detected, splenic mass changed due to active
immunization against GnRH in experiment. Unfortunately, very few
articles demonstrate the physiological mechanisms of immunomodulation
in such conditions. In any case, the obvious insufficiency and inconsistency
of publications on each aspect of GnRH effects indicate that they
are still poorly understood, and it is worth furthering not only
applied but also fundamental studies in this direction, particularly
in the context of developing effective systems for immune control.